Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7970
+0.0149 (1.91%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $18.4 million as of March 20, 2026. Its market cap has increased by 1,100.98% in one year.
Market Cap
18.40M
Enterprise Value
14.28M
1-Year Change
1,100.98%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $18.40M, a decrease of -71.81%. That is a compound annual growth rate of -24.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 18.40M | -38.22% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 20.64M |
| Acurx Pharmaceuticals | 18.93M |
| Daré Bioscience | 18.58M |
| Citius Pharmaceuticals | 18.18M |
| Lexaria Bioscience | 18.04M |
| Traws Pharma | 17.42M |
| Allarity Therapeutics | 17.39M |
| FibroBiologics | 17.30M |